Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG40933

EIF2AK2 Knockout CaSki Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Squamous cell carcinoma

CRISPR/Cas9-edited polyclonal knockout cell population targeting EIF2AK2 (PKR) in the Ca Ski human cervical carcinoma background. These cells harbor integrated HPV-16 and express E6/E7 oncoproteins, providing a model for HPV-related research. PKR is a dsRNA-activated kinase that phosphorylates eIF2??, inhibiting translation and activating NF-??B and MAPK pathways to induce antiviral responses and apoptosis. This PKR knockout model enables dissection of innate immune signaling, stress granule dynamics, and translational control in a virally transformed context. Ideal for antiviral studies, apoptosis assays, and drug screening, it supports techniques such as phospho-signaling analysis, co-immunoprecipitation, and reporter-based pathway interrogation.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    CaSki

    Sex of Donor

    Female

    Age

    40 years

    Derived From Site

    Metastatic; Small intestine

    Gene Name

    EIF2AK2

    Gene Identifier

    NCBI Gene ID 5610

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The EIF2AK2 Knockout Ca Ski Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population in which the EIF2AK2 gene, encoding the double-stranded RNA-activated protein kinase (PKR), has been disrupted. This loss-of-function model is generated in the Ca Ski host background and is provided as a polyclonal pool, enabling functional studies of PKR-dependent signaling without the confounding effects of clonal variation. The targeting strategy achieves gene disruption across the population, offering a robust tool for investigating the role of PKR in antiviral innate immunity, translational control, and stress response pathways.

Ca Ski cells are a human cervical squamous cell carcinoma line that contains an integrated HPV-16 genome and constitutively expresses the viral oncoproteins E6 and E7. This makes them a well-established carcinoma model for HPV-related research, particularly for studying virus?Chost interactions, oncogenic transformation, and the cellular response to viral infection. The presence of the HPV genome creates a physiologically relevant context in which to examine the intersection of viral immune evasion and host antiviral defenses, including those mediated by PKR.

PKR is a serine/threonine kinase activated by double-stranded RNA, interferons, PACT, and other stress signals such as tumor necrosis factor, lipopolysaccharide, and oxidative stress. Upon activation, PKR autophosphorylates and subsequently phosphorylates its primary substrate, eIF2??, leading to a global translational arrest that blocks viral replication. In addition, PKR functions upstream of I??B phosphorylation, promoting NF-??B nuclear translocation and the induction of interferon-stimulated genes. It also phosphorylates p38 MAPK and JNK, activating AP-1 transcription factors, and can trigger caspase-3-mediated apoptosis. PKR interacts with key regulatory proteins including PACT, TRBP, Hsp90, and viral antagonists such as HCV NS5A and Vaccinia E3L.

In the Ca Ski host cell background, the knockout of PKR provides a unique model to dissect how HPV-associated oncogenesis modulates innate immune signaling and stress responses. Since E6 and E7 proteins can subvert host defense mechanisms, the absence of PKR allows researchers to evaluate its specific contribution to translational control, apoptosis regulation, and NF-??B/MAPK pathway activity in the context of persistent HPV infection. This system is particularly valuable for identifying PKR-dependent mechanisms that may be exploited for therapeutic intervention in cervical cancer and other HPV-related malignancies.

This knockout product is suitable for a broad range of applications including antiviral innate immunity studies, translation regulation analysis, stress granule dynamics, apoptosis signaling, and cancer cell stress responses. Representative assays include Western blotting for phospho-eIF2?? and phospho-PKR, RT-qPCR for interferon-stimulated genes, immunofluorescence for stress granule formation, flow cytometry for apoptosis, co-immunoprecipitation for PKR interactions, and reporter assays for NF-??B or interferon-responsive elements. The EIF2AK2 Knockout Ca Ski Polyclonal Cells thus offer a versatile platform for both basic research and drug discovery screening targeting PKR-related pathways. For detailed technical specifications and ordering information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)